Dendreon Pharmaceuticals Llc Is A Biotechnology Company Based In Seal Beachcaliforniaspecializing In Cellular Immunotherapythe Company Is Recognized For Developing Provengea Sipuleucel T The First Fda Approved Autologous Cellular Immunotherapy For Prostate Cancerdendreon Focuses On Advancing Personalized Cancer Treatments By Activating The Immune Systemwith Nearly 40 000 Patients Having Received Provenge As Of 2023 Founded In The Early 1990Sdendreon Has Evolved Significantlyespecially After Its Acquisition By Chinaae S Sanpower Group In 2017The Company Offers Comprehensive Support For The Clinical Developmentmanufacturingand Commercialization Of Cell Therapiesemphasizing Logisticsquality Controland Regulatory Compliancedendreon Collaborates With Biotech Firms To Develop Next Generation Cell Therapiesleveraging Its Expertise In Cellular Therapy Manufacturing To Improve Patient Outcomes
